Market Movers

Walgreens Boots Alliance, Inc.’s Stock Price Takes a Hit, Plunging to $17.26 Amidst a 3.09% Dip

Walgreens Boots Alliance, Inc. (WBA)

17.26 USD -0.55 (-3.09%) Volume: 11.45M

Walgreens Boots Alliance, Inc.’s stock price is currently standing at 17.26 USD, reflecting a trading session decrease of -3.09%. The trading volume for WBA is at 11.45M, showcasing a significant market interest. However, the stock has experienced a notable year-to-date decline of -33.90%, indicating a challenging period for investors.


Latest developments on Walgreens Boots Alliance, Inc.

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) has seen significant stock price movements recently, driven by a series of key events. The Swiss National Bank and Russell Investments Group Ltd. have both reduced their stock positions in the company, generating some market uncertainty. However, not all investors are retreating, as evidenced by New York Life Investment Management LLC’s purchase of an additional 690 shares. Despite these fluctuations, Federated Hermes Inc. has also decided to sell 1126 of its shares in Walgreens Boots Alliance.


Walgreens Boots Alliance, Inc. on Smartkarma

Analysts on Smartkarma are closely monitoring Walgreens Boots Alliance, a company that recently reported its second-quarter operational results. Baptista Research notes that the company’s adjusted EPS of $1.20 reflects cost discipline and strong performance in the U.S. Retail Pharmacy segment. The research report evaluates various factors that could impact the company’s stock price in the near future, using a Discounted Cash Flow methodology.

Meanwhile, Travis Lundy’s analysis focuses on Walgreens Boots Alliance being removed from the Dow Jones Industrial Average. Historically, companies removed from the index tend to outperform in the next six months. The report highlights that WBA is cheaper than CVS and discusses the implications of the company’s deletion from the index, with Amazon.com Inc set to replace it. These insights provide valuable information for investors tracking Walgreens Boots Alliance‘s performance.


A look at Walgreens Boots Alliance, Inc. Smart Scores

FactorScoreMagnitude
Value5
Dividend5
Growth2
Resilience2
Momentum3
OVERALL SMART SCORE3.4

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Walgreens Boots Alliance, Inc. has received high scores in Value and Dividend, indicating a positive long-term outlook for the company. With a strong focus on providing a wide range of prescription and non-prescription drugs, as well as general goods, Walgreens continues to be a key player in the retail drugstore industry. Despite lower scores in Growth and Resilience, the company’s commitment to offering health services such as primary and acute care, wellness, pharmacy services, and disease management positions it well for future success.

Although Walgreens Boots Alliance scored lower in Growth and Resilience, its Momentum score of 3 suggests a moderate level of positive market momentum. With a solid foundation in Value and Dividend, the company’s diverse range of services, including health and fitness offerings, showcases its ability to adapt to changing consumer needs. Overall, Walgreens’ position as a leading retail drugstore chain, coupled with its strong performance in Value and Dividend, bodes well for its long-term outlook in the market.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars